Growth Metrics

908 Devices (MASS) Cash from Investing Activities Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -253.01%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -11.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -41.67%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -472.46%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -16.93%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -111.03%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -40.94%
10 908 Devices 314.43 Mn 202.69 Mn 6.88 Mn -18.88%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -18.88%
Dec 31, 2025 135.90%
Sep 30, 2025 33.12%
Jun 30, 2025 -443.93%
Mar 31, 2025 337.16%
Dec 31, 2024 154.30%
Sep 30, 2024 306.85%
Jun 30, 2024 -318.38%
Mar 31, 2024 -762.77%
Sep 30, 2023 -288.54%
Jun 30, 2023 -498.48%
Mar 31, 2023 -135.27%